NCT03949621View on ClinicalTrials.gov

A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 6, 2018

Primary Completion Date

July 2, 2018

Study Completion Date

August 13, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Vedolizumab SC

Vedolizumab SC liquid.

Trial Locations (1)

85283

Celerion, Tempe

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03949621 - A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants | Biotech Hunter | Biotech Hunter